HEADER CELL CYCLE 18-OCT-22 8H6T TITLE COMPLEX STRUCTURE OF CDK2/CYCLIN E1 AND A POTENT, SELECTIVE SMALL TITLE 2 MOLECULE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-DEPENDENT KINASE 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CELL DIVISION PROTEIN KINASE 2,P33 PROTEIN KINASE; COMPND 5 EC: 2.7.11.22; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: G1/S-SPECIFIC CYCLIN-E1; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: RESIDUES 103-373; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CDK2, CDKN2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: CCNE1, CCNE; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, COMPLEX, SELECTIVE, ANTI-TUMOR, CELL CYCLE EXPDTA X-RAY DIFFRACTION AUTHOR X.REN REVDAT 3 20-SEP-23 8H6T 1 REMARK REVDAT 2 29-MAR-23 8H6T 1 JRNL REVDAT 1 22-FEB-23 8H6T 0 JRNL AUTH Y.YU,J.HUANG,H.HE,J.HAN,G.YE,T.XU,X.SUN,X.CHEN,X.REN,C.LI, JRNL AUTH 2 H.LI,W.HUANG,Y.LIU,X.WANG,Y.GAO,N.CHENG,N.GUO,X.CHEN,J.FENG, JRNL AUTH 3 Y.HUA,C.LIU,G.ZHU,Z.XIE,L.YAO,W.ZHONG,X.CHEN,W.LIU,H.LI JRNL TITL ACCELERATED DISCOVERY OF MACROCYCLIC CDK2 INHIBITOR QR-6401 JRNL TITL 2 BY GENERATIVE MODELS AND STRUCTURE-BASED DRUG DESIGN. JRNL REF ACS MED.CHEM.LETT. V. 14 297 2023 JRNL REFN ISSN 1948-5875 JRNL PMID 36923916 JRNL DOI 10.1021/ACSMEDCHEMLETT.2C00515 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0258 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.32 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 15514 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.254 REMARK 3 R VALUE (WORKING SET) : 0.249 REMARK 3 FREE R VALUE : 0.358 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 797 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.08 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1147 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.50 REMARK 3 BIN R VALUE (WORKING SET) : 0.3500 REMARK 3 BIN FREE R VALUE SET COUNT : 43 REMARK 3 BIN FREE R VALUE : 0.3990 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4627 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 24 REMARK 3 SOLVENT ATOMS : 2 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 86.15 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.58000 REMARK 3 B22 (A**2) : 4.58000 REMARK 3 B33 (A**2) : -9.16000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.602 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.530 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 31.511 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.922 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.766 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4772 ; 0.008 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 4517 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6479 ; 1.689 ; 1.644 REMARK 3 BOND ANGLES OTHERS (DEGREES): 10474 ; 1.199 ; 1.577 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 568 ; 8.137 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 236 ;36.421 ;22.415 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 837 ;21.217 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 25 ;15.926 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 606 ; 0.071 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5191 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 996 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2278 ; 8.784 ; 9.094 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2277 ; 8.771 ; 9.093 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2844 ;13.080 ;13.608 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2845 ;13.079 ;13.610 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2494 ; 7.742 ; 9.473 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2495 ; 7.741 ; 9.472 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3636 ;11.852 ;14.052 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 5515 ;16.085 ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 5516 ;16.083 ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 8H6T COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-OCT-22. REMARK 100 THE DEPOSITION ID IS D_1300032946. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-DEC-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL02U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 S 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16618 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 45.320 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.02245 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.7700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.30280 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.330 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 1W98 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M SODIUM CITRATE PH 6.5, 10% REMARK 280 PEG3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.80850 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 50.98500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 50.98500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 37.90425 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 50.98500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 50.98500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 113.71275 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 50.98500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 50.98500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 37.90425 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 50.98500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 50.98500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 113.71275 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 75.80850 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3470 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24490 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 8 137.53 -173.18 REMARK 500 ARG A 50 -70.10 -59.43 REMARK 500 GLU A 81 135.85 -33.98 REMARK 500 ASP A 127 45.29 -150.49 REMARK 500 ASP A 145 78.35 78.65 REMARK 500 ARG A 150 126.07 -176.12 REMARK 500 TPO A 160 116.65 -8.81 REMARK 500 HIS A 161 -75.32 -57.99 REMARK 500 VAL A 164 129.74 67.71 REMARK 500 LYS A 178 -79.37 -79.21 REMARK 500 SER A 181 -144.25 -146.12 REMARK 500 ARG A 199 50.62 31.04 REMARK 500 PHE A 203 66.76 -150.59 REMARK 500 PRO A 204 46.75 -74.67 REMARK 500 THR A 221 115.44 -31.31 REMARK 500 VAL A 225 -72.44 -69.77 REMARK 500 TRP A 227 80.62 -162.84 REMARK 500 PHE A 240 133.46 -39.15 REMARK 500 ARG A 245 153.27 -40.03 REMARK 500 PRO A 254 4.80 -61.46 REMARK 500 SER A 261 -71.74 -61.85 REMARK 500 VAL B 107 104.27 -44.40 REMARK 500 LYS B 125 -83.07 -96.65 REMARK 500 THR B 126 -43.04 -16.48 REMARK 500 HIS B 132 54.86 -110.88 REMARK 500 HIS B 137 51.28 -115.27 REMARK 500 PHE B 173 -80.56 -40.55 REMARK 500 ASN B 182 94.34 43.87 REMARK 500 TYR B 206 75.09 -113.62 REMARK 500 GLU B 230 -35.44 -37.91 REMARK 500 ASN B 260 -162.22 43.02 REMARK 500 ASP B 261 -71.79 -75.82 REMARK 500 LEU B 262 99.89 -62.95 REMARK 500 HIS B 263 66.92 -58.83 REMARK 500 LEU B 284 -82.58 -74.76 REMARK 500 CYS B 285 -34.48 -16.85 REMARK 500 SER B 308 -108.75 -148.53 REMARK 500 TRP B 321 -38.97 -36.82 REMARK 500 GLU B 325 -46.83 -23.70 REMARK 500 ALA B 353 -170.36 -50.86 REMARK 500 GLU B 355 37.90 -65.63 REMARK 500 ASP B 356 -3.69 -152.13 REMARK 500 SER B 366 -24.12 60.30 REMARK 500 LEU B 367 -77.57 -36.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8H6O RELATED DB: PDB REMARK 900 8H6O CONTAINS THE SAME PROTEIN COMPONENTS WITH DIFFERENT LIGAND REMARK 900 RELATED ID: 8H6P RELATED DB: PDB REMARK 900 8H6P CONTAINS THE SAME PROTEIN COMPONENTS WITH DIFFERENT LIGAND DBREF 8H6T A 1 297 UNP P24941 CDK2_HUMAN 1 297 DBREF 8H6T B 102 373 UNP P24864 CCNE1_HUMAN 102 373 SEQADV 8H6T PRO A 0 UNP P24941 EXPRESSION TAG SEQRES 1 A 298 PRO MET GLU ASN PHE GLN LYS VAL GLU LYS ILE GLY GLU SEQRES 2 A 298 GLY THR TYR GLY VAL VAL TYR LYS ALA ARG ASN LYS LEU SEQRES 3 A 298 THR GLY GLU VAL VAL ALA LEU LYS LYS ILE ARG LEU ASP SEQRES 4 A 298 THR GLU THR GLU GLY VAL PRO SER THR ALA ILE ARG GLU SEQRES 5 A 298 ILE SER LEU LEU LYS GLU LEU ASN HIS PRO ASN ILE VAL SEQRES 6 A 298 LYS LEU LEU ASP VAL ILE HIS THR GLU ASN LYS LEU TYR SEQRES 7 A 298 LEU VAL PHE GLU PHE LEU HIS GLN ASP LEU LYS LYS PHE SEQRES 8 A 298 MET ASP ALA SER ALA LEU THR GLY ILE PRO LEU PRO LEU SEQRES 9 A 298 ILE LYS SER TYR LEU PHE GLN LEU LEU GLN GLY LEU ALA SEQRES 10 A 298 PHE CYS HIS SER HIS ARG VAL LEU HIS ARG ASP LEU LYS SEQRES 11 A 298 PRO GLN ASN LEU LEU ILE ASN THR GLU GLY ALA ILE LYS SEQRES 12 A 298 LEU ALA ASP PHE GLY LEU ALA ARG ALA PHE GLY VAL PRO SEQRES 13 A 298 VAL ARG THR TYR TPO HIS GLU VAL VAL THR LEU TRP TYR SEQRES 14 A 298 ARG ALA PRO GLU ILE LEU LEU GLY CYS LYS TYR TYR SER SEQRES 15 A 298 THR ALA VAL ASP ILE TRP SER LEU GLY CYS ILE PHE ALA SEQRES 16 A 298 GLU MET VAL THR ARG ARG ALA LEU PHE PRO GLY ASP SER SEQRES 17 A 298 GLU ILE ASP GLN LEU PHE ARG ILE PHE ARG THR LEU GLY SEQRES 18 A 298 THR PRO ASP GLU VAL VAL TRP PRO GLY VAL THR SER MET SEQRES 19 A 298 PRO ASP TYR LYS PRO SER PHE PRO LYS TRP ALA ARG GLN SEQRES 20 A 298 ASP PHE SER LYS VAL VAL PRO PRO LEU ASP GLU ASP GLY SEQRES 21 A 298 ARG SER LEU LEU SER GLN MET LEU HIS TYR ASP PRO ASN SEQRES 22 A 298 LYS ARG ILE SER ALA LYS ALA ALA LEU ALA HIS PRO PHE SEQRES 23 A 298 PHE GLN ASP VAL THR LYS PRO VAL PRO HIS LEU ARG SEQRES 1 B 272 GLY SER PRO LEU PRO VAL LEU SER TRP ALA ASN ARG GLU SEQRES 2 B 272 GLU VAL TRP LYS ILE MET LEU ASN LYS GLU LYS THR TYR SEQRES 3 B 272 LEU ARG ASP GLN HIS PHE LEU GLU GLN HIS PRO LEU LEU SEQRES 4 B 272 GLN PRO LYS MET ARG ALA ILE LEU LEU ASP TRP LEU MET SEQRES 5 B 272 GLU VAL CYS GLU VAL TYR LYS LEU HIS ARG GLU THR PHE SEQRES 6 B 272 TYR LEU ALA GLN ASP PHE PHE ASP ARG TYR MET ALA THR SEQRES 7 B 272 GLN GLU ASN VAL VAL LYS THR LEU LEU GLN LEU ILE GLY SEQRES 8 B 272 ILE SER SER LEU PHE ILE ALA ALA LYS LEU GLU GLU ILE SEQRES 9 B 272 TYR PRO PRO LYS LEU HIS GLN PHE ALA TYR VAL THR ASP SEQRES 10 B 272 GLY ALA CYS SER GLY ASP GLU ILE LEU THR MET GLU LEU SEQRES 11 B 272 MET ILE MET LYS ALA LEU LYS TRP ARG LEU SER PRO LEU SEQRES 12 B 272 THR ILE VAL SER TRP LEU ASN VAL TYR MET GLN VAL ALA SEQRES 13 B 272 TYR LEU ASN ASP LEU HIS GLU VAL LEU LEU PRO GLN TYR SEQRES 14 B 272 PRO GLN GLN ILE PHE ILE GLN ILE ALA GLU LEU LEU ASP SEQRES 15 B 272 LEU CYS VAL LEU ASP VAL ASP CYS LEU GLU PHE PRO TYR SEQRES 16 B 272 GLY ILE LEU ALA ALA SER ALA LEU TYR HIS PHE SER SER SEQRES 17 B 272 SER GLU LEU MET GLN LYS VAL SER GLY TYR GLN TRP CYS SEQRES 18 B 272 ASP ILE GLU ASN CYS VAL LYS TRP MET VAL PRO PHE ALA SEQRES 19 B 272 MET VAL ILE ARG GLU THR GLY SER SER LYS LEU LYS HIS SEQRES 20 B 272 PHE ARG GLY VAL ALA ASP GLU ASP ALA HIS ASN ILE GLN SEQRES 21 B 272 THR HIS ARG ASP SER LEU ASP LEU LEU ASP LYS ALA MODRES 8H6T TPO A 160 THR MODIFIED RESIDUE HET TPO A 160 11 HET WZZ A 301 24 HETNAM TPO PHOSPHOTHREONINE HETNAM WZZ (1R,3S)-3-{3-[(PYRIDIN-2-YL)AMINO]-1H-PYRAZOL-5- HETNAM 2 WZZ YL}CYCLOPENTYL PROPAN-2-YLCARBAMATE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO C4 H10 N O6 P FORMUL 3 WZZ C17 H23 N5 O2 FORMUL 4 HOH *2(H2 O) HELIX 1 AA1 PRO A 45 GLU A 57 1 13 HELIX 2 AA2 LEU A 87 SER A 94 1 8 HELIX 3 AA3 PRO A 100 HIS A 121 1 22 HELIX 4 AA4 LYS A 129 GLN A 131 5 3 HELIX 5 AA5 THR A 165 ARG A 169 5 5 HELIX 6 AA6 ALA A 170 LEU A 175 1 6 HELIX 7 AA7 THR A 182 ARG A 199 1 18 HELIX 8 AA8 SER A 207 GLY A 220 1 14 HELIX 9 AA9 GLY A 229 MET A 233 5 5 HELIX 10 AB1 ASP A 247 VAL A 252 1 6 HELIX 11 AB2 ASP A 256 LEU A 267 1 12 HELIX 12 AB3 SER A 276 HIS A 283 1 8 HELIX 13 AB4 PRO A 284 GLN A 287 5 4 HELIX 14 AB5 ASN B 112 TYR B 127 1 16 HELIX 15 AB6 GLN B 141 TYR B 159 1 19 HELIX 16 AB7 HIS B 162 ALA B 178 1 17 HELIX 17 AB8 VAL B 184 GLU B 204 1 21 HELIX 18 AB9 LYS B 209 THR B 217 1 9 HELIX 19 AC1 SER B 222 LEU B 237 1 16 HELIX 20 AC2 THR B 245 TYR B 258 1 14 HELIX 21 AC3 PRO B 271 VAL B 286 1 16 HELIX 22 AC4 ASP B 288 PHE B 294 5 7 HELIX 23 AC5 PRO B 295 SER B 308 1 14 HELIX 24 AC6 SER B 309 GLY B 318 1 10 HELIX 25 AC7 GLN B 320 GLY B 342 1 23 HELIX 26 AC8 ASP B 356 ILE B 360 5 5 HELIX 27 AC9 SER B 366 LYS B 372 1 7 SHEET 1 AA1 5 PHE A 4 GLY A 13 0 SHEET 2 AA1 5 GLY A 16 ASN A 23 -1 O LYS A 20 N GLU A 8 SHEET 3 AA1 5 VAL A 29 ARG A 36 -1 O VAL A 30 N ALA A 21 SHEET 4 AA1 5 LYS A 75 GLU A 81 -1 O PHE A 80 N ALA A 31 SHEET 5 AA1 5 LEU A 66 THR A 72 -1 N LEU A 67 O VAL A 79 SHEET 1 AA2 3 GLN A 85 ASP A 86 0 SHEET 2 AA2 3 LEU A 133 ILE A 135 -1 O ILE A 135 N GLN A 85 SHEET 3 AA2 3 ILE A 141 LEU A 143 -1 O LYS A 142 N LEU A 134 SHEET 1 AA3 2 VAL A 123 LEU A 124 0 SHEET 2 AA3 2 ARG A 150 ALA A 151 -1 O ARG A 150 N LEU A 124 LINK C TYR A 159 N TPO A 160 1555 1555 1.35 LINK C TPO A 160 N HIS A 161 1555 1555 1.35 CRYST1 101.970 101.970 151.617 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009807 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009807 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006596 0.00000